Kadmon

Discussion in 'Kadmon Pharmaceuticals' started by Anonymous, Feb 26, 2014 at 11:40 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    OMG. I Just ordered Alex Prud'hommes' book "the cell game" from ITunes. The best $1.99 I ever spent.
     

  2. Anonymous

    Anonymous Guest

    I dont get it...how can we be laying off people with generic meds? This is the Obama medicine way...we should be doing booming business.
     
  3. Anonymous

    Anonymous Guest

    well, looks like the new CCO is cleaning house and trying to salvage the company.....can we say too little too late!!! If you were not looking before, dust of your resume and make it a priority. leadership is at an all time low....even with KM gone.
     
  4. Anonymous

    Anonymous Guest

    Webmaster, why are you taking down posts that are not in violation of your terms of use policy? In doing so you're compromising the true spirt of cafe pharma.
     
  5. Anonymous

    Anonymous Guest

    heard from a buddy at genetech that DB is trying to make inroads...looks like all the rats are jumping ship. not long before the rest of the chosen ones [JP, RL, etc...] start to run too now that their lord and master is gone!!!!!!!
     
  6. Anonymous

    Anonymous Guest

    Watch the excitement as a wave of long-standing higher up moves on or is squeezed out. This is one way to transform but not ethical. Anyone not bolted down heading for the hills. Be careful with this place.
     
  7. Anonymous

    Anonymous Guest

    What happened to the Queens Rep?
     
  8. Anonymous

    Anonymous Guest

    2nd lawsuit in as many months ...

    Waksal Sued by Barred Ex-John Thomas Head Belesis Over Deal
    June 29, 2015 — 2:19 PM EDT Updated on June 29, 2015 — 7:30 PM EDT

    Convicted insider trader Sam Waksal was accused of cheating former brokerage head Anastasios “Tommy” Belesis in a stock deal allegedly designed to sidestep the U.S. ban on Waksal serving as a public company’s officer.

    Belesis said Waksal failed to meet the terms of a stock-purchase agreement tied to Kadmon Pharmaceuticals LLC. Belesis claims he’s still owed $15 million by Waksal, who started Kadmon after leaving prison.

    Waksal, previously ImClone Systems Inc.’s chief executive officer, served a five-year term for telling his daughter to sell her ImClone shares a day before U.S. regulators rejected the company’s application for a colon cancer drug. His friend, lifestyle and design entrepreneur Martha Stewart, was also convicted and sent to prison in the stock scandal.

    Belesis said in his complaint filed Monday in Manhattan federal court that he agreed ahead of a planned initial public offering to renounce his interest in 1 million shares of Kadmon stock in exchange for $15 million. Waksal never paid him, said Belesis, the founder of defunct brokerage John Thomas Financial Inc. who was expelled from the securities industry for trading ahead of his clients,

    The 2010 deal was designed to avoid disclosure to investors and circumvent restrictions imposed upon Waksal by federal prosecutors and regulators after he pleaded guilty to insider trading and settled a related insider-trading case by the U.S. Securities and Exchange Commission, according to Belesis.

    Alleged Deception
    “In order to deceive the court and the public and to perpetuate a fraud upon the public in connection with Kadmon’s anticipated initial public offer, Waksal carried out a plan, scheme, and course of conduct which was intended to and did deceive actual and potential investors,” Belesis said in his lawsuit.

    Kadmon remains a closely held company. Waksal told CNBC in a September 2014 interview that Kadmon was planning an initial public offering.

    Belesis included excerpts from an e-mail he said he got from a Kadmon lawyer, which refers to the federal restrictions placed upon Waksal after he was convicted and settled the SEC case. Waksal was barred for life from acting as an officer or director of any publicly traded company.

    “In substance, we are still thinking the mechanism through Sam Waksal will personally convey to Tommy Belesis, in compensation for Tommy’s personal assistance to Sam in trying to work around” the regulatory restrictions, the lawyer said in the e-mail.
    Personal Funds

    Belesis said Waksal agreed to pay him from his personal funds rather than corporate money.
    In January, Belesis was barred from the brokerage industry for life by the Financial Industry Regulatory Authority after regulators said he dumped the New York-based firm’s position in a penny stock that was surging while 14 customers tried and failed to sell their shares.
    Before the Finra action, Belesis played a minor role in the movie “Wall Street: Money Never Sleeps.” That was before his boiler room across from the New York Stock Exchange closed in 2013.

    Kadmon was sued in New York state court in 2013 by a John Thomas Financial broker, Kevin Glodek, who said he’s owed at least $4 million in commission and other fees after he helped Waksal raise $40 million in 2012 from unidentified investors.
    Disputed Claims

    Kadmon, in a response to that suit in April, disputed Glodek’s allegations and said it paid a commission to John Thomas Financial. Kadmon said the now-defunct brokerage isn’t entitled to payment “because it was not, and is not, a member in good standing with Finra,” and claims Glodek and the brokerage took too long to file the suit.

    Judith Mogul, a lawyer for Kadmon in the state lawsuit, and Ellen Tremaine, a spokeswoman for Kadmon, didn’t immediately respond to voice-mail messages seeking comment on the cases.

    The case is Belesis v. Waksal, 15-cv-05048, U.S. District Court, Southern District of New York (Manhattan.) The state case is Kevin Glodek v. Kadmon Holdings LLC, 652116/2013, New York State Supreme Court (Manhattan).
     
  9. anonymous

    anonymous Guest

    Sorry to hear about Q being dropped from the Express Scripts Prefered Drug List.
    Karma is a bich
     
  10. anonymous

    anonymous Guest

    Who is still posting? I thought all the reps were let go???
     
  11. anonymous

    anonymous Guest

    Layoffs Dec 24th; my contact in the home office said its true
     
  12. anonymous

    anonymous Guest

    Additional layoffs?
     
  13. anonymous

    anonymous Guest

    Reporter here:
    Can you comment on the nature of the co-promotion with Valeant?
    Thanks!
     
  14. anonymous

    anonymous Guest

    Did I actually see a Kadmon rep in the field yesterday? I thought you guys just stayed home and laid low?
     
  15. anonymous

    anonymous Guest

    Products are over and the team is over. HQ is out of their minds.d